Global Bacterial Vaginosis OTC Drug Market Insights, Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Bacterial Vaginosis OTC Drug Product Introduction 1.2 Market by Type 1.2.1 Global Bacterial Vaginosis OTC Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Pill 1.2.3 Gel 1.2.4 Cream 1.2.5 Other 1.3 Market by Application 1.3.1 Global Bacterial Vaginosis OTC Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Pharmacy 1.3.3 On-line 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Bacterial Vaginosis OTC Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Bacterial Vaginosis OTC Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Bacterial Vaginosis OTC Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Bacterial Vaginosis OTC Drug Sales by Region 2.4.1 Global Bacterial Vaginosis OTC Drug Sales by Region (2017-2022) 2.4.2 Global Sales Bacterial Vaginosis OTC Drug by Region (2023-2028) 2.5 Global Bacterial Vaginosis OTC Drug Revenue by Region 2.5.1 Global Bacterial Vaginosis OTC Drug Revenue by Region (2017-2022) 2.5.2 Global Bacterial Vaginosis OTC Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Bacterial Vaginosis OTC Drug Sales by Manufacturers 3.1.1 Global Top Bacterial Vaginosis OTC Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Bacterial Vaginosis OTC Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bacterial Vaginosis OTC Drug in 2021 3.2 Global Bacterial Vaginosis OTC Drug Revenue by Manufacturers 3.2.1 Global Bacterial Vaginosis OTC Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Bacterial Vaginosis OTC Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Bacterial Vaginosis OTC Drug Revenue in 2021 3.3 Global Bacterial Vaginosis OTC Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Bacterial Vaginosis OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Bacterial Vaginosis OTC Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Bacterial Vaginosis OTC Drug Sales by Type 4.1.1 Global Bacterial Vaginosis OTC Drug Historical Sales by Type (2017-2022) 4.1.2 Global Bacterial Vaginosis OTC Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2028) 4.2 Global Bacterial Vaginosis OTC Drug Revenue by Type 4.2.1 Global Bacterial Vaginosis OTC Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Bacterial Vaginosis OTC Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Bacterial Vaginosis OTC Drug Revenue Market Share by Type (2017-2028) 4.3 Global Bacterial Vaginosis OTC Drug Price by Type 4.3.1 Global Bacterial Vaginosis OTC Drug Price by Type (2017-2022) 4.3.2 Global Bacterial Vaginosis OTC Drug Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Bacterial Vaginosis OTC Drug Sales by Application 5.1.1 Global Bacterial Vaginosis OTC Drug Historical Sales by Application (2017-2022) 5.1.2 Global Bacterial Vaginosis OTC Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2028) 5.2 Global Bacterial Vaginosis OTC Drug Revenue by Application 5.2.1 Global Bacterial Vaginosis OTC Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Bacterial Vaginosis OTC Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Bacterial Vaginosis OTC Drug Revenue Market Share by Application (2017-2028) 5.3 Global Bacterial Vaginosis OTC Drug Price by Application 5.3.1 Global Bacterial Vaginosis OTC Drug Price by Application (2017-2022) 5.3.2 Global Bacterial Vaginosis OTC Drug Price Forecast by Application (2023-2028)6 North America 6.1 North America Bacterial Vaginosis OTC Drug Market Size by Type 6.1.1 North America Bacterial Vaginosis OTC Drug Sales by Type (2017-2028) 6.1.2 North America Bacterial Vaginosis OTC Drug Revenue by Type (2017-2028) 6.2 North America Bacterial Vaginosis OTC Drug Market Size by Application 6.2.1 North America Bacterial Vaginosis OTC Drug Sales by Application (2017-2028) 6.2.2 North America Bacterial Vaginosis OTC Drug Revenue by Application (2017-2028) 6.3 North America Bacterial Vaginosis OTC Drug Market Size by Country 6.3.1 North America Bacterial Vaginosis OTC Drug Sales by Country (2017-2028) 6.3.2 North America Bacterial Vaginosis OTC Drug Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada7 Europe 7.1 Europe Bacterial Vaginosis OTC Drug Market Size by Type 7.1.1 Europe Bacterial Vaginosis OTC Drug Sales by Type (2017-2028) 7.1.2 Europe Bacterial Vaginosis OTC Drug Revenue by Type (2017-2028) 7.2 Europe Bacterial Vaginosis OTC Drug Market Size by Application 7.2.1 Europe Bacterial Vaginosis OTC Drug Sales by Application (2017-2028) 7.2.2 Europe Bacterial Vaginosis OTC Drug Revenue by Application (2017-2028) 7.3 Europe Bacterial Vaginosis OTC Drug Market Size by Country 7.3.1 Europe Bacterial Vaginosis OTC Drug Sales by Country (2017-2028) 7.3.2 Europe Bacterial Vaginosis OTC Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Bacterial Vaginosis OTC Drug Market Size by Type 8.1.1 Asia Pacific Bacterial Vaginosis OTC Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Bacterial Vaginosis OTC Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Bacterial Vaginosis OTC Drug Market Size by Application 8.2.1 Asia Pacific Bacterial Vaginosis OTC Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Bacterial Vaginosis OTC Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Bacterial Vaginosis OTC Drug Market Size by Region 8.3.1 Asia Pacific Bacterial Vaginosis OTC Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Bacterial Vaginosis OTC Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia9 Latin America 9.1 Latin America Bacterial Vaginosis OTC Drug Market Size by Type 9.1.1 Latin America Bacterial Vaginosis OTC Drug Sales by Type (2017-2028) 9.1.2 Latin America Bacterial Vaginosis OTC Drug Revenue by Type (2017-2028) 9.2 Latin America Bacterial Vaginosis OTC Drug Market Size by Application 9.2.1 Latin America Bacterial Vaginosis OTC Drug Sales by Application (2017-2028) 9.2.2 Latin America Bacterial Vaginosis OTC Drug Revenue by Application (2017-2028) 9.3 Latin America Bacterial Vaginosis OTC Drug Market Size by Country 9.3.1 Latin America Bacterial Vaginosis OTC Drug Sales by Country (2017-2028) 9.3.2 Latin America Bacterial Vaginosis OTC Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Bacterial Vaginosis OTC Drug Market Size by Type 10.1.1 Middle East and Africa Bacterial Vaginosis OTC Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Bacterial Vaginosis OTC Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Bacterial Vaginosis OTC Drug Market Size by Application 10.2.1 Middle East and Africa Bacterial Vaginosis OTC Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Bacterial Vaginosis OTC Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Bacterial Vaginosis OTC Drug Market Size by Country 10.3.1 Middle East and Africa Bacterial Vaginosis OTC Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Bacterial Vaginosis OTC Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Bayer 11.1.1 Bayer Corporation Information 11.1.2 Bayer Overview 11.1.3 Bayer Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bayer Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bayer Recent Developments 11.2 Pfizer 11.2.1 Pfizer Corporation Information 11.2.2 Pfizer Overview 11.2.3 Pfizer Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Pfizer Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer Recent Developments 11.3 Sanofi 11.3.1 Sanofi Corporation Information 11.3.2 Sanofi Overview 11.3.3 Sanofi Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Sanofi Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Sanofi Recent Developments 11.4 Piramal 11.4.1 Piramal Corporation Information 11.4.2 Piramal Overview 11.4.3 Piramal Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Piramal Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Piramal Recent Developments 11.5 Abbott 11.5.1 Abbott Corporation Information 11.5.2 Abbott Overview 11.5.3 Abbott Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Abbott Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Abbott Recent Developments 11.6 Galderma 11.6.1 Galderma Corporation Information 11.6.2 Galderma Overview 11.6.3 Galderma Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Galderma Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Galderma Recent Developments 11.7 Mission 11.7.1 Mission Corporation Information 11.7.2 Mission Overview 11.7.3 Mission Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Mission Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Mission Recent Developments 11.8 Alkem 11.8.1 Alkem Corporation Information 11.8.2 Alkem Overview 11.8.3 Alkem Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Alkem Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Alkem Recent Developments 11.9 Xiuzheng 11.9.1 Xiuzheng Corporation Information 11.9.2 Xiuzheng Overview 11.9.3 Xiuzheng Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Xiuzheng Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Xiuzheng Recent Developments 11.10 Teva 11.10.1 Teva Corporation Information 11.10.2 Teva Overview 11.10.3 Teva Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Teva Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Teva Recent Developments 11.11 Perrigo 11.11.1 Perrigo Corporation Information 11.11.2 Perrigo Overview 11.11.3 Perrigo Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Perrigo Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Perrigo Recent Developments 11.12 West-Ward 11.12.1 West-Ward Corporation Information 11.12.2 West-Ward Overview 11.12.3 West-Ward Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 West-Ward Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 West-Ward Recent Developments 11.13 HPGC 11.13.1 HPGC Corporation Information 11.13.2 HPGC Overview 11.13.3 HPGC Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 HPGC Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 HPGC Recent Developments 11.14 Yunnan Baiyao 11.14.1 Yunnan Baiyao Corporation Information 11.14.2 Yunnan Baiyao Overview 11.14.3 Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Yunnan Baiyao Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Yunnan Baiyao Recent Developments 11.15 Starpharma 11.15.1 Starpharma Corporation Information 11.15.2 Starpharma Overview 11.15.3 Starpharma Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Starpharma Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Starpharma Recent Developments 11.16 Novel 11.16.1 Novel Corporation Information 11.16.2 Novel Overview 11.16.3 Novel Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Novel Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Novel Recent Developments 11.17 Edenvridge 11.17.1 Edenvridge Corporation Information 11.17.2 Edenvridge Overview 11.17.3 Edenvridge Bacterial Vaginosis OTC Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 Edenvridge Bacterial Vaginosis OTC Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 Edenvridge Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Bacterial Vaginosis OTC Drug Industry Chain Analysis 12.2 Bacterial Vaginosis OTC Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Bacterial Vaginosis OTC Drug Production Mode & Process 12.4 Bacterial Vaginosis OTC Drug Sales and Marketing 12.4.1 Bacterial Vaginosis OTC Drug Sales Channels 12.4.2 Bacterial Vaginosis OTC Drug Distributors 12.5 Bacterial Vaginosis OTC Drug Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Bacterial Vaginosis OTC Drug Industry Trends 13.2 Bacterial Vaginosis OTC Drug Market Drivers 13.3 Bacterial Vaginosis OTC Drug Market Challenges 13.4 Bacterial Vaginosis OTC Drug Market Restraints14 Key Findings in The Global Bacterial Vaginosis OTC Drug Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer